LON:VRCI Verici Dx (VRCI) Share Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free VRCI Stock Alerts GBX 7.25 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range 7▼ 7.5050-Day Range 7.25▼ 11.7952-Week Range 5.50▼ 19Volume833,243 shsAverage Volume378,028 shsMarket Capitalization£17.58 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get Verici Dx alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Verici Dx Stock (LON:VRCI)Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its lead products comprise Tutivia, a post-transplant test focused on acute rejection, including sub-clinical rejection; and Clarava, a pre-transplant prognosis test for the risk of early acute rejection. The company also develops Protega, a peripheral blood-based test that aims to predict the risk of fibrosis and long-term graft failure. Verici Dx plc was incorporated in 2020 and is based in Penarth, the United Kingdom.Read More VRCI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VRCI Stock News HeadlinesApril 23, 2024 | americanbankingnews.comVerici Dx (LON:VRCI) Trading Down 0.3%February 24, 2024 | morningstar.comVerici Dx PLC Ordinary Shares VRCIApril 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 1, 2024 | morningstar.comVerici Dx PLC Ordinary SharesNovember 10, 2023 | finance.yahoo.comVerici Dx plc (63V.F)July 25, 2023 | finance.yahoo.comCompanies Like Verici Dx (LON:VRCI) Could Be Quite RiskyMay 25, 2023 | finance.yahoo.comDX - Dynex Capital, Inc.February 16, 2023 | finance.yahoo.comCloud DX Announces Private Placements of up to an Aggregate of $5.5 Million with Lead Orders of $1.5 MillionApril 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 15, 2023 | finance.yahoo.comWe're Keeping An Eye On Verici Dx's (LON:VRCI) Cash Burn RateJanuary 18, 2023 | benzinga.comDynex Cap Stock (NYSE:DX), Quotes and News SummarySeptember 8, 2022 | finance.yahoo.comWe Think Verici Dx (LON:VRCI) Needs To Drive Business Growth CarefullySeptember 3, 2022 | uk.finance.yahoo.comVerici Dx plc (VRCI.L)June 14, 2022 | marketwatch.comVerici Releases Data on Tuteva Blood Test; Shares DiveMay 5, 2022 | finance.yahoo.comAmerican Shared Hospital Services Announces First Quarter 2022 Earnings Conference CallApril 9, 2022 | lse.co.ukVerici Dx Share ChatMarch 26, 2022 | investing.comVerici Dx Plc (VRCI)See More Headlines Receive VRCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Verici Dx and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolLON:VRCI CUSIPN/A CIKN/A Webwww.vericidx.com Phone44 207 9338780FaxN/AEmployees14Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-11,210,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-92.28% Return on Assets-47.86% Debt Debt-to-Equity Ratio9.28 Current Ratio2.58 Quick Ratio8.49 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 5.71 per share Price / Cash Flow1.31 Book ValueGBX 4 per share Price / Book1.88Miscellaneous Outstanding Shares242,540,000Free FloatN/AMarket Cap£18.19 million OptionableNot Optionable Beta1.48 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMs. Sara Barrington A.C.A. (Age 57)A.C.I.M., CEO & Executive Director Comp: $281.77kMr. David M. Anderson (Age 61)Chief Financial Officer Mr. Salim Gulamabbas Hamir F.C.A.Company SecretaryKey CompetitorsYourgene HealthLON:YGENGENinCodeLON:GENIAbingdon HealthLON:ABDXProteome SciencesLON:PRMLungLife AILON:LLAIView All Competitors VRCI Stock Analysis - Frequently Asked Questions How have VRCI shares performed in 2024? Verici Dx's stock was trading at GBX 9.75 at the beginning of 2024. Since then, VRCI stock has decreased by 25.6% and is now trading at GBX 7.25. View the best growth stocks for 2024 here. How do I buy shares of Verici Dx? Shares of VRCI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:VRCI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryYou Won't Believe Who Bezos is Working With to Fight Alzheimer'sBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verici Dx plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
